X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2026-02-15 | VANI | Vivani Medical, Inc. | Williams Gregg | Dir, 10% | P - Purchase | $1.06 | +1,866,492 | 34,581,152 | +6% | +$1,983,333 | ||||||
| D | 2026-02-13 | XFLH | Xflh Capital Corp | Xflh Holdings Ltd | 10% | P - Purchase | $10.00 | +154,970 | 3,818,303 | +4% | +$1,549,700 | |||||
| D | 2026-02-12 | ZIVO | Zivo Bioscience, Inc. | Strome Mark E | 10% | P - Purchase | $9.77 | +20,000 | 472,942 | +4% | +$195,400 | |||||
2026-02-13 | ASST | Strive, Inc. | Beirne Brian Logan | GC | P - Purchase | $8.73 | +11,500 | 15,204 | +310% | +$100,387 | ||||||
2026-02-12 | VTSI | Virtra, Inc | Brown Jeffrey Dale | Dir | P - Purchase | $4.48 | +6,860 | 64,053 | +12% | +$30,724 | ||||||
2026-02-12 | ENTX | Entera Bio Ltd. | Rubin Steven D | Dir | P - Purchase | $1.49 | +5,000 | 15,000 | +50% | +$7,450 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |